.jpg "KakaoTalk_20240311_093519751_10(1).jpg")
CHAMEDITECH participated in the Dubai Derma 2024 conference held in Dubai, United Arab Emirates from March 5 to March 7. Dubai Derma is the largest skin care exhibition held in North Africa and the Indian subcontinent and is held every year in Dubai. On March 6, the second day of the conference, a lecture was held on 'CELLTERMI REVIVE NX', a skin booster containing 'Nidogen' and 'Exosome', a famous human-derived material, and visitors to the booth showed interest in CHAMEDITECH's various products. CHAMEDITECH also had time to consult with visitors.
Meanwhile, CELLTERMI REVIVE NX contains 'CHA-MD-Exosome (Exosome, Extracellular Vesicles)', a patented raw material based on human-derived materials with high biocompatibility, and 'Nidogen-1' is a product that helps improve the overall skin environment, including moisturizing and elasticity as well as soothing.
‘CHA-MD-Exosome’ is an exosome derived from human lactic acid bacteria for which CHAMEDITECH has applied for a patent as its proprietary ingredient. According to CHAMEDITECH, it reduces redness and increases transparency during skin aging caused by external environmental stimuli such as ultraviolet rays or harmful bacteria. In addition, 'Nidogen', one of the four major protein components of the skin's basement membrane, is also the main ingredient of REVIVE NX. It helps strengthen the skin's basement membrane function, something that has never been attempted before in existing skin boosters. It is expected to moisturize the skin as well as improve elasticity, shine, and skin texture.
Following the previously released CELLTERMI REVIVE PCL (polycaprolactone), CHAMEDITECH has expanded the 'topical skin booster' market beyond Korea to the global market with the launch of REVIVE NX.